Hunter S and McLaren P. Specialist medical training and the Calman report. Br Med J1993; 306: 1281.
2.
ArcherDF, et al.
Endometrial effects of tibolone.J Clin Endocrinol Metab2007;
92: 911–918.
3.
VivagradovaY, et al.
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ2019;
364: k4810.
